|
Books > Business & Economics > Industry & industrial studies > Manufacturing industries
Transcultural Artificial Intelligence and Robotics in Health and
Social Care provides healthcare professionals with a deeper
understanding of the incredible opportunities brought by the
emerging field of AI robotics. In addition, it provides robotic
researchers with the point-of-view of healthcare professionals to
understand what the healthcare sector - as well as the market -
really needs from robotics technology. By doing so, the book fills
an important gap between both fields in order to leverage new
developments and collaborative work in favor of global patients.
The book is aimed at the non-technical reader, especially health
and social care professionals, and explains in a simple way the
technological principles applied in the development of socially
assistive humanoid AI robots (SAHR), the values which guide such
developments, the ethics related to them, and research approaches
in the field, with a focus on achieving a culturally competent
SAHR.
Now with a new afterword covering the months-long landmark trials
of Elizabeth Holmes and Sunny Balwani. ‘I couldn’t put down
this thriller . . . the perfect book to read by the fire this
winter.’ Bill Gates Winner of the Financial Times/McKinsey
Business Book of the Year Award 2018 The riveting true story of the
breathtaking rise and shocking collapse of Theranos, the
multibillion-dollar biotech startup founded by Elizabeth Holmes, by
the prize-winning journalist who first broke the story and pursued
it to the end, despite pressure from its charismatic CEO and
threats by her lawyers. In 2014, Theranos founder and CEO Elizabeth
Holmes was widely seen as the female Steve Jobs: a brilliant
Stanford dropout whose startup ‘unicorn’ promised to
revolutionize the medical industry with a machine that would make
blood testing significantly faster and easier. Backed by investors
such as Larry Ellison and Tim Draper, Theranos sold shares in a
fundraising round that valued the company at more than $9 billion,
putting Holmes’s worth at an estimated $4.7 billion. There was
just one problem: the technology didn’t work. In Bad Blood, John
Carreyrou tells the riveting story of the biggest corporate fraud
since Enron, a tale of ambition and hubris set amid the bold
promises of Silicon Valley. ‘Chilling . . . Reads like a West
Coast version of All the President’s Men.’ New York Times Book
Review
Roadmap to Successful Digital Health Ecosystems: A Global
Perspective presents evidence-based solutions found on adopting
open platforms, standard information models, technology neutral
data repositories, and computable clinical data and knowledge
(ontologies, terminologies, content models, process models, and
guidelines), resulting in improved patient, organizational, and
global health outcomes. The book helps engaging countries and
stakeholders take action and commit to a digital health strategy,
create a global environment and processes that will facilitate and
induce collaboration, develop processes for monitoring and
evaluating national digital health strategies, and enable learnings
to be shared in support of WHO's global strategy for digital
health. The book explains different perspectives and local
environments for digital health implementation, including
data/information and technology governance, secondary data use,
need for effective data interpretation, costly adverse events,
models of care, HR management, workforce planning, system
connectivity, data sharing and linking, small and big data, change
management, and future vision. All proposed solutions are based on
real-world scientific, social, and political evidence.
Stimuli-Responsive Nanocarriers: Recent Advances in Tailor-Made
Therapeutics compiles dispersed knowledge into a complete and
comprehensive source to help researchers understand and progress
stimuli-responsive nanocarriers. The book contains recent
advancements made in the field of stimuli-responsive nanocarriers
with their application in controlled drug delivery against various
diseases. It focuses on the design, mechanism, construction,
therapeutic application and future challenges of stimuli-responsive
nanocarriers which will help new researchers in designing next
generation tailor-made advanced therapeutics. Finally, the book
covers future aspects and challenges present in the route of
development of stimuli responsive nanocarriers for disease
therapeutics. Various recent advances and biomedical applications
assembled in this book will guide scientists on how to design and
develop novel controlled drug release systems.
The fourth industrial revolution is having a major impact on
industry and societies primarily because of what has been called
its raw material: data. New technologies are allowing
hyper-connection on a global scale, not only between people, but
also between people and machines and, in the case of the Internet
of Things, even amongst machines themselves. This book offers a
critical reflection on the meaning and expected consequences of the
fourth industrial revolution, with a particular focus on the advent
of digital globalisation and its implications for industrial
policy. Industrial revolutions are considered not only in terms of
technological progress, but also in the context of the changing
relationship between market and production dynamics, and the social
and political conditions enabling the development of new
technologies. Industrial Policy for the Manufacturing Revolution
aims to increase our capacity to anticipate and adapt to the
forthcoming structural changes. It outlines the type of industrial
policy and strategies that are needed in this era of rapid
transformation. The authors propose a 'comprehensive industrial
policy' that considers the complexity of structural changes
involving industry as well as institutions and social and education
policies, in order to encourage the participation of all citizens
in the development process. The book also features a concrete
example of comprehensive industrial policy implementation at the
regional level. This stimulating and thoughtful book makes the case
that industrial policies are more vital than ever, particularly now
as the economy undergoes a technological revolution. It will be
required reading for all those interested in industrial economics
and policy, business and technology.
Regulatory Affairs in the Pharmaceutical Industry is a
comprehensive reference that compiles all the information available
pertaining to regulatory procedures currently followed by the
pharmaceutical industry. Designed to impart advanced knowledge and
skills required to learn the various concepts of regulatory
affairs, the content covers new drugs, generic drugs and their
development, regulatory filings in different countries, different
phases of clinical trials, and the submission of regulatory
documents like IND (Investigational New Drug), NDA (New Drug
Application) and ANDA (Abbreviated New Drug Application). Chapters
cover documentation in the pharmaceutical industry, generic drug
development, code of Federal Regulation (CFR), the ANDA regulatory
approval process, the process and documentation for US registration
of foreign drugs, the regulation of combination products and
medical devices, the CTD and ECTD formats, and much more.
Bioinformatics for Everyone provides a brief overview on currently
used technologies in the field of bioinformatics-interpreted as the
application of information science to biology- including various
online and offline bioinformatics tools and softwares. The book
presents valuable knowledge in a simplified way to help students
and researchers easily apply bioinformatics tools and approaches to
their research and lab routines. Several protocols and case studies
that can be reproduced by readers to suit their needs are also
included.
Micro and Nano Systems for Biophysical Studies of Cells and Small
Organisms provides a comprehensive introduction to the
state-of-the-art micro and nano systems that have recently been
developed and applied to biophysical studies of cells and small
organisms. These micro and nano systems span from
microelectromechanical systems (MEMS) and microfluidic devices to
robotic micro-nanomanipulation systems. These biophysical studies
range from cell mechanics to the neural science of worms and
Drosophila. This book will help readers understand the fundamentals
surrounding the development of these tools and teach them the most
recent advances in cellular and organismal biophysics enabled by
these technologies.
Bioinspired and Biomimetic Materials for Drug Delivery delves into
the potential of bioinspired materials in drug delivery, detailing
each material type and its latest developments. In the last decade,
biomimetic and bioinspired materials and technology has garnered
increased attention in drug delivery research. Various material
types including polymer, small molecular, protein, peptide,
cholesterol, polysaccharide, nano-crystal and hybrid materials are
widely considered in drug delivery research. However, biomimetic
and bioinspired materials and technology have shown promising
results for use in therapeutics, due to their high biocompatibility
and reduced immunogenicity. Such materials include dopamine,
extracellular exosome, bile acids, ionic liquids, and red blood
cell. This book covers each of these materials in detail, reviewing
their potential and usage in drug delivery. As such, this book will
be a great source of information for biomaterials scientists,
biomedical engineers and those working in pharmaceutical research.
Pharmaceuticals in Marine and Coastal Environments: Occurrence,
Effects, and Challenges in a Changing World is divided into three
sections that address a) coastal areas as the main entrance of
pharmaceuticals into the ocean, b) the occurrence and distribution
of pharmaceuticals in the environmental compartments of the ocean
media, and c) the effects that such pollutants may cause to the
exposed marine organisms. With its comprehensive discussions, the
book provides a wide depiction of the current state-of-the-art on
these topics in an effort to open new sources of investigation and
find suitable solutions.
As technology advances, it is imperative to stay current in the
newest developments made within the engineering industry and within
material sciences. Trends in manufacturing such as 3D printing,
casting, welding, surface modification, computer numerical control
(CNC), non-traditional, Industry 4.0 ergonomics, and hybrid
machining methods must be closely examined to utilize these
important resources for the betterment of society. Advanced
Manufacturing Techniques for Engineering and Engineered Materials
provides a unified and complete overview about the recent and
emerging trends, developments, and associated technology with scope
for the commercialization of techniques specific to manufacturing
materials. This book also reviews the various machining methods for
difficult-to-cut materials and novel materials including matrix
composites. Covering topics such as agro-waste, conventional
machining, and material performance, this book is an essential
resource for researchers, engineers, technologists, students and
professors of higher education, industry workers, entrepreneurs,
researchers, and academicians.
|
You may like...
Research Matters
Franzel du Plooy-Cilliers, Corne Davis, …
Paperback
R497
Discovery Miles 4 970
|